LMR Partners’s Novo Nordisk NVO Stock Holding History

LMR Partners’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.5M	Sell	285,000 -357,300	-56%	-$16.9M	0.02%	404
2025 Q4	$32.7M	Buy	642,300 +232,300	+57%	+$11.9M	0.06%	141
2025 Q3	$22.8M	Buy	410,000 +284,900	+228%	+$16.7M	0.1%	155
2025 Q2	$8.63M	Buy	125,100 +115,100	+1,151%	+$7.83M	0.06%	315
2025 Q1	$694K	Sell	10,000 -10,000	-50%	-$826K	0.01%	856
2024 Q4	$1.72M	Sell	20,000 -15,900	-44%	-$1.72M	0.01%	637
2024 Q3	$4.27M	Buy	+35,900	New	+$4.79M	0.03%	403
2024 Q1	–	Sell	-15,600	Closed	-$1.61M	–	1266
2023 Q4	$1.61M	Sell	15,600 -211,400	-93%	-$20.9M	0.02%	511
2023 Q3	$20.6M	Sell	227,000 -276,600	-55%	-$24.4M	0.23%	107
2023 Q2	$40.7M	Buy	+503,600	New	+$41.1M	0.45%	48

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

LMR Partners's NVO Position: Q1 2026 in Review

LMR Partners reduced its Novo Nordisk (NVO) stake by 36% in Q1 2026, selling an estimated $1.71M and leaving 63,871 shares worth $2.35M. The position accounts for 0.01% of the portfolio, ranked #824.

LMR Partners first reported a position in NVO in Q2 2022 and has held it in 12 quarters since. The position peaked at $8.3M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

LMR Partners held 63,871 shares of Novo Nordisk worth $2.35M as of Q1 2026.
LMR Partners sold 36,129 Novo Nordisk shares in Q1 2026, an estimated $1.71M.
Novo Nordisk made up 0.01% of LMR Partners's portfolio in Q1 2026, its #824 holding.
LMR Partners first reported a position in Novo Nordisk in Q2 2022 and has held it in 12 quarters since.
LMR Partners's Novo Nordisk position peaked at $8.3M in Q2 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.